<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Dasari A</submitter><funding>NCI NIH HHS</funding><journal>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</journal><pagination>JCO2018789032</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6286158</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies.</pubmed_title><pmcid>PMC6286158</pmcid><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>R01 CA184843</funding_grant_id><pubmed_authors>Grothey A</pubmed_authors><pubmed_authors>Kopetz S</pubmed_authors><pubmed_authors>Dasari A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Circulating Tumor DNA-Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2025-04-26T03:18:30.758Z</modification><creation>2025-04-06T10:41:17.338Z</creation></dates><accession>S-EPMC6286158</accession><cross_references><pubmed>30376428</pubmed><doi>10.1200/JCO.2018.78.9032</doi><doi>10.1200/jco.2018.78.9032</doi></cross_references></HashMap>